Patent Assignment
Reel/Frame 069037/0940
Assignment of Assignor's Interest
Recorded: 2024-09-26
Pages: 3
Assignee
MYELOID THERAPEUTICS, INC.
300 TECHNOLOGY SQUARE, SUITE 203, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
Application:
18/674,029 →
Publication:
US 2024/0391998
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.